Skip to content

13F-HR filed by ENAVATE SCIENCES GP, LLC

ENAVATE SCIENCES GP, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:21:06 UTC, with 8 holding rows worth $279,763,966.

Accession
0001953107-26-000019
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 8 entries on the cover page, a total value of $279,763,966 stated on the cover page (in dollars after the unit check, H1), rows summing to $279,763,966 with VALUE read as dollars as filed, 13F file number 028-25306. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ZENAS BIOPHARMA INC COM98937L105Stock2,919,159$78,729,718dollars as filed
IMMUNOME INC45257U108COM3,613,799$77,732,816dollars as filed
Braveheart Bio Inc10567X101COM3,674,656$74,228,051dollars as filed
SIONNA THERAPEUTICS INC829401108COMMON STOCK2,478,030$13,034,438dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK2,459,703$12,962,635dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW2,626,946$10,770,479dollars as filed
COMPASS THERAPEUTICS INC20454B104COM7,788,150$8,099,676dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM1,041,127$4,206,153dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001953107-26-000019this filing2026-11-16